Recent Research Grants

  • NIH/NIAID (Morse) HIV/AIDS Clinical Trial Unit. Andrew Talal (Co-Principal Investigator). 12/1/2013-4/1/2028.
  • Mab Passive Vaccination against Acinetobacter baumannii. Thomas Russo (Co-Investigator). NIAID/NIH. $485,053. 9/1/2022-8/1/2027.
  • Novel Combination Therapies to Combat Hypermutable Carbapenem-Resistant P. aeruginosa. Thomas Russo (Co-Investigator). NIAID/NIH. 5/1/2022-4/1/2027.
  • Impacts of Nicotinamide Riboside on functional capacity and muscle physiology in older veterans. Nikhil Satchidanand (Co-Investigator). Veterans Affairs. 1/1/2022-12/1/2026.
  • A brief, transdiagnostic cognitive behavioral treatment for urologic chronic pelvic pain syndrome (UCPPS): Process, predictions, outcomes. Tova Ablove (Co-Investigator), Teresa Danforth (Co-Investigator), Gregory Gudleski (Co-Investigator), Jeffrey Lackner (Principal Investigator), Brian Quigley (Co-Investigator), Christopher Radziwon (Co-Investigator), Alison Vargovich (Co-Investigator). NIH NIDDK. $3,288,753. 9/1/2021-7/1/2026.
  • VA Merit Review, 2IO1BX002659, Preventing and Reversing Interstitial Fibrosis in HFpEF. John Canty, Jr. (Principal Investigator). Department of Veterans Affairs. $709,984. 7/1/2020-6/1/2026.
  • Research Training on Alcohol Etiology and Treatment. Brian Quigley (Contributor). NIAAA. $2,508,143. 5/1/2021-4/1/2026.
  • Immunomodulation of Galectin-3 to Prevent Radiation-Induced Myocardial Fibrogenesis. Umesh Sharma (Principal Investigator). NHLBI. $1,726,588. 3/1/2021-3/1/2026.
  • Physician Advisor - NIH - R01-Grant Sleep Effects on Post-Stroke Rehabilitation. Eric Ten Brock (Principal Investigator). $3,051,980. 1/1/2021-1/1/2026.
  • Inhibition of Radiation-Induced Coronary Microvascular Disease. Supriya Mahajan (Co-Investigator). NIH. $1,750,000. 9/1/2020-8/1/2025.
  • Sex related differences in Brain Gut Microbiome (BGM) Interactions in Irritable Bowel Syndrome. Jeffrey Lackner (Co-Investigator). NIH NIDDK. $7,757,028. 5/1/2020-4/1/2025.
  • Clinical and Translational Science Award: Buffalo Clinical and Translational Research Center. Timothy Murphy (Principal Investigator). National Center for Advancing Translational Sciences. $19,101,902. 8/1/2019-12/1/2024.
  • Buffalo Clinical and Translational Research Center Clinical and Translational Science Award(CTSA). Jeffrey Lackner (Co-Investigator), Ram Samudrala (Co-Investigator). National Center for Advancing Translational Sciences (NCATS)/National Institutes of Health. $20,000,000. 8/1/2015-8/1/2024.
  • Genome Evolution During Bacterial Persistence in the Human Airways in COPD. Timothy Murphy (Principal Investigator). NIAID. $2,653,298. 7/1/2019-6/1/2024.
  • NIH/NIDDK (Shapiro) Disparities in the Diffusion of Direct-Acting Antiviral Therapy for Hepatitis C among Baby Boomers: A Mixed-Methods Study. Andrew Talal (Co-Principal Investigator). 8/1/2020-6/1/2024.
  • Effectiveness of Combining Behavioral and Pharmacologic Therapy for Complex Insomnia in Veterans With PTSD (PRECEPT-D). Ali El Solh (Principal Investigator). US Department of Veterans Affairs. 5/1/2019-5/1/2024.
  • University at Buffalo Behavioral Health Workforce Expansion Program Scholars (UB BHWET Scholars): Expanding the Behavioral Health Workforce for High Need and High Demand Areas. Alison Vargovich (Contributor). US DHHS/HRSA. $2,800,000. 1/1/2020-1/1/2024.
  • University at Buffalo Opioid Workforce Expansion Program ScholarsScholars (UB OWEP Scholars): Expanding the Opioid Workforce for High Need and High Demand Areas. Alison Vargovich (Contributor). US DHHS/HRSA Grant. $1,350,000. 1/1/2020-1/1/2024.
  • Prediction of Arrhythmic Events with Positron Emission Tomography - II (PAREPET II). John Canty, Jr. (Co-Principal Investigator). National Heart Lung and Blood Institute - NHLBI. $3,726,616. 11/1/2016-12/1/2023.
  • A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis. Andrew Talal (Principal Investigator). Intercept Pharmaceuticals. 1/1/2018-12/1/2023.